Ginkgo Bioworks Holdings Inc. (DNA) at a glance

Ginkgo Bioworks Holdings Inc. (DNA) is a small-cap Healthcare company. It trades at $6.96, with a -219.6% profit margin and revenue decline of 48.5%. It does not pay a dividend. Vestovix scores it 30/100 overall. Its strongest dimension is Value (48/100) and its weakest is Growth (11/100). It carries above-market volatility, so expect larger swings.

Price

$6.96

Market cap

$473.4M

P/E ratio

n/a

Dividend yield

None

Beta

1.79

52-week range

$5.37 to $17.58